Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 50 /hr
Hire Timeo M.
United Kingdom
USD 50 /hr

Clinical Trial Manager. Provide clinical research expertise for all phase (I to III) trials globally

Profile Summary
Subject Matter Expertise
Services
Writing Clinical Trial Documentation, Medical Writing, Technical Writing
Research Scientific and Technical Research, Systematic Literature Review
Consulting Digital Strategy Consulting, Healthcare Consulting, Scientific and Technical Consulting, Regulatory Consulting
Data & AI Statistical Analysis, Data Visualization, Data Processing, Data Insights
Work Experience

University of Oxford

- Present

Clinical Trial Manager

University of Oxford

October 2023 - June 2026

Clinical Trials Coordinator

Kamuzu University of Health science (KUHeS)

August 2022 - September 2023

Clinical Trials Coordinator

Malawi Liverpool Welcome research program

December 2020 - July 2022

Research Clinical Officer

Dignitas International Organisation

September 2015 - December 2017

Education

MSc in Clinical Trials (London School of Hygiene and Tropical Medicine (LSHTM))

University Of London

December 2020 - December 2023

BSC in Public Health

ShareWorld University

January 2016 - November 2018

Diploma in Clinical Medicine

Malawi Adventist University ( Malamulo College of Health Sciences)

April 2012 - January 2013

Certifications
  • PRINCE2 Practitioner- Project management

    PeopleCert

    April 2026 - Present

  • Essential guide on grant applications

    NIHR

    April 2024 - Present

  • Leadership and Management in health

    University of Washington

    January 2021 - Present

  • Risk Management

    Malawi Liverpool Wellcome trust

    January 2021 - Present

  • CH-GCP (E6 R3)

    NIHR, University of Oxford

    January 2026 - December 2026

Publications
JOURNAL ARTICLE
Burke RM, Nyirenda SK, Mtenga T, Twabi HH, Joekes E, Walker NF, Nyirenda R, Gupta-Wright A, Nliwasa M, Fielding K, et al.(2025). Enhanced Tuberculosis Diagnosis With Computer-aided Chest X-ray and Urine Lipoarabinomannan in Adults With HIV Admitted to Hospital (CASTLE Study): A Cluster Randomized Trial . Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Timeo Mtenga, Rachael M Burke, Saulos K Nyirenda, Hussein H Twabi, Elizabeth Joekes, Naomi F Walker, Rose Nyirenda, Ankur Gupta-Wright, Marriott Nliwasa, Katherine Fielding, et al. (2024). Enhanced Tuberculosis Diagnosis With Computer-aided Chest X-ray and Urine Lipoarabinomannan in Adults With HIV Admitted to Hospital (CASTLE Study): A Cluster Randomized Trial . Clinical Infectious Diseases.
Gerber F, Semphere R, Lukau B, Mahlatsi P, Mtenga T, Lee T, Kohler M, Glass TR, Amstutz A, Molatelle M, et al.(2024). Same-day versus rapid ART initiation in HIV-positive individuals presenting with symptoms of tuberculosis: Protocol for an open-label randomized non-inferiority trial in Lesotho and Malawi . PloS one.
Felix Gerber, Robina Semphere, Blaise Lukau, P.A. Mahlatsi, Tristan Lee, Michaela Kohler, Tracy R. Glass, Alain Amstutz, Mamello Molatelle, et al., Timeo Mtenga (2023). Same-day versus rapid ART initiation in HIV-positive individuals presenting with symptoms of tuberculosis: protocol for an open-label randomized non-inferiority trial in Lesotho and Malawi . PLOS ONE.
PREPRINT
RESEARCH TECHNIQUE
Timeo Mtenga, Oliver FitzGerald, Laura Coates, Stephen R. Pennington, Teresa Grohmann, Michaela Koehm, Rudolf Horvath, Mari Hoff, Burkhard Moller, Theodoros Dimitroulas The protocol of a patient-driven on-line prospective European observational cohort aiming to determine risk factors for the development of psoriatic arthritis (PsA) amongst people living with psoriasis:.